Literature DB >> 11721673

Gentamicin dosing in neonatal patients.

N Gooding1, A Elias-Jones, M Shenoy.   

Abstract

OBJECTIVE: To compare trough and peak serum gentamicin concentrations in neonatal patients using two dosing regimens.
METHOD: A retrospective audit of gentamicin serum concentrations obtained with the current neonatal gentamicin-dosing regimen (regimen 1) was conducted. Results were then compared with the introduction of a new regimen (regimen 2). Preliminary results necessitated a change to a further dosage schedule (regimen 3), where data was again collected.
RESULTS: For regimen 1, 79% of patients achieved satisfactory trough concentrations, 30% achieved satisfactory peak concentrations, and 16% achieved a satisfactory combined trough and peak concentration. For regimen 2, 80% of patients achieved satisfactory trough concentrations, 63% achieved satisfactory peak concentrations, and 48% achieved a satisfactory combined trough and peak concentration. For regimen 3, 76% of patients achieved satisfactory trough concentrations, 56% achieved satisfactory peak concentrations, and 45% achieved a satisfactory combined trough and peak concentration.
CONCLUSION: Regimen 3 shows a marked improvement in serum gentamicin concentrations. However neonates in the 32-38 weeks post-conceptional age group achieved higher trough and peak serum gentamicin levels than expected. Therefore the dosage interval in this group of neonates will be increased from 18 hourly to 24 hourly dosing, and regimen reaudited.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721673     DOI: 10.1023/a:1012221801816

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  6 in total

1.  Acute effects of gentamicin on glomerular and tubular functions in preterm neonates.

Authors:  Sevinç Tugay; Zelal Bircan; Ciğdem Cağlayan; Ayşe Engin Arisoy; Ayşe Sevim Gökalp
Journal:  Pediatr Nephrol       Date:  2006-08-01       Impact factor: 3.714

Review 2.  Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.

Authors:  E Nestaas; H-J Bangstad; L Sandvik; K-O Wathne
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-04-27       Impact factor: 5.747

3.  Pharmacological differences between once daily and twice daily gentamicin dosage in newborns with suspected sepsis.

Authors:  Inge Hagen; Knut Øymar
Journal:  Pharm World Sci       Date:  2008-11-04

4.  Gentamicin usage in newborns--a simple and practical regime.

Authors:  Monika Bajaj; Katherine Palmer
Journal:  Pharm World Sci       Date:  2004-08

Review 5.  Therapeutic drug monitoring of aminoglycosides in neonates.

Authors:  Daniël J Touw; Elsbeth M Westerman; Arwen J Sprij
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

Review 6.  Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries.

Authors:  Gary L Darmstadt; Mary Miller-Bell; Maneesh Batra; Paul Law; Kiely Law
Journal:  J Health Popul Nutr       Date:  2008-06       Impact factor: 2.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.